Preparation, Optimization, and Anti-Pulmonary Infection Activity of Casein-Based Chrysin Nanoparticles
DOI: https://doi.org/10.2147/ijn.s457643
IF: 7.033
2024-06-11
International Journal of Nanomedicine
Abstract:Huaqiao Tang, 1, &ast Liying Dong, 1, &ast Xue Xia, 1, &ast Xinling Chen, 1 Meichen Ren, 1 Gang Shu, 1 Hualin Fu, 1 Juchun Lin, 1 Ling Zhao, 1 Li Zhang, 2 Guoqiang Cheng, 2 Xianxiang Wang, 3 Wei Zhang 1 1 College of Veterinary, Sichuan Agricultural University, Chengdu, 611130, People's Republic of China; 2 Sichuan Academy of Chinese Medicine Sciences, Chengdu, 610041, People's Republic of China; 3 College of Science, Sichuan Agricultural University, Chengdu, 611130, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei Zhang, Email Introduction: Chrysin has a wide range of biological activities, but its poor bioavailability greatly limits its use. Here, we attempted to prepare casein (cas)-based nanoparticles to promote the biotransfer of chrysin, which demonstrated better bioavailability and anti-infection activity compared to free chrysin. Methods: Cas-based chrysin nanoparticles were prepared and characterized, and most of the preparation process was optimized. Then, the in vitro and in vivo release characteristics were studied, and anti-pulmonary infection activity was evaluated. Results: The constructed chrysin-cas nanoparticles exhibited nearly spherical morphology with particle size and ζ potential of 225.3 nm and − 33 mV, respectively. These nanoparticles showed high encapsulation efficiency and drug-loading capacity of 79.84% ± 1.81% and 11.56% ± 0.28%, respectively. In vitro release studies highlighted a significant improvement in the release profile of the chrysin-cas nanoparticles (CCPs). In vivo experiments revealed that the relative oral bioavailability of CCPs was approximately 2.01 times higher than that of the free chrysin suspension. Further investigations indicated that CCPs effectively attenuated pulmonary infections caused by Acinetobacter baumannii by mitigating oxidative stress and reducing pro-inflammatory cytokines levels, and the efficacy was better than that of the free chrysin suspension. Conclusion: The findings underscore the advantageous bioavailability of CCPs and their protective effects against pulmonary infections. Such advancements position CCPs as a promising pharmaceutical agent and candidate for future therapeutic drug innovations. Keywords: chrysin, nanoparticles, Acinetobacter baumannii , casein Chrysin, a flavonoid abundant in passion flowers, honey, and propolis, exhibits diverse pharmacological properties, which include anti-inflammatory, antioxidant, anti-allergic, anti-diabetic, and anti-tumor activities. 1 Chrysin exhibited robust anti-inflammatory properties in an investigation of smoke-induced acute respiratory inflammation in mice by inhibiting activation of the MAPK pathway and protecting against lung injury. 2 Chrysin mitigated lipopolysaccharide-induced acute lung injury in mice by improving vascular permeability and reducing pulmonary tissue inflammation. 3 Extensive research has identified chrysin as a promising therapeutic agent in diverse disease models, while its poor water solubility, low intestinal absorption, significant first-pass effect, diminished oral bioavailability, weak in vivo efficacy, and rapid systemic elimination greatly limit its wider application. 4 Conventional formulations encounter difficulties in improving solubility associated with poorly soluble drugs. Nanoparticles have gained recognition as an innovative drug delivery system extensively utilized for administering drugs with poor water solubility. Casein, the principal protein in milk, demonstrates substantial stability, safety, non-toxicity, inherent biocompatibility, and biodegradability. These attributes position it as an ideal drug delivery carrier for enhancing bioavailability. 5,6 Cas is a deblock copolymer with amphiphilic structures capable of self-assembling in water, forming core-shell complexes. The hydrophobic inner chains aggregate to form the core, while the hydrophilic outer chains create the shell of the complex. 7 This allows for the physical entrapment or chemical conjugation of hydrophobic drugs within the core, enabling the development of innovative nano-drug delivery systems. 8 Cas-based drug delivery systems improved the solubility and bioavailability of poorly soluble drugs to amplify drug dissolution and increased drug release rates by 1.5–2 times. 9,10 Cas was shown to protect oral and esophageal epithelium from drug-induced toxicity, establishing it as a promising candidate for oral drug delivery. 11 No do -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology